F269-0081 Screening compound: N-[3-methyl-1-(4-methyl-6-oxo-1,6-dihydropyrimidin-2-yl)-1H-pyrazol-5-yl]-4-(piperidine-1-sulfonyl)benzamide

F269-0081 Screening compound: N-[3-methyl-1-(4-methyl-6-oxo-1,6-dihydropyrimidin-2-yl)-1H-pyrazol-5-yl]-4-(piperidine-1-sulfonyl)benzamide
F269-0081 Screening compound: N-[3-methyl-1-(4-methyl-6-oxo-1,6-dihydropyrimidin-2-yl)-1H-pyrazol-5-yl]-4-(piperidine-1-sulfonyl)benzamide alternative view

Chemical Structure Depiction of ChemDiv screening compound F269-0081
N-[3-methyl-1-(4-methyl-6-oxo-1,6-dihydropyrimidin-2-yl)-1H-pyrazol-5-yl]-4-(piperidine-1-sulfonyl)benzamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

F269-0081

Molecular Formula

C21H24N6O4S (C21 H24 N6 O4 S)

Compound Name

N-[3-methyl-1-(4-methyl-6-oxo-1,6-dihydropyrimidin-2-yl)-1H-pyrazol-5-yl]-4-(piperidine-1-sulfonyl)benzamide

IUPAC name

N-[3-methyl-1-(4-methyl-6-oxo-16-dihydropyrimidin-2-yl)-1H-pyrazol-5-yl]-4-(piperidine-1-sulfonyl)benzamide

SMILES

Cc(cc1NC(c(cc2)ccc2S(N2CCCCC2)(=O)=O)=O)nn1C(N1)=NC(C)=CC1=O

InChI

InChI=1S/C21H24N6O4S/c1-14-13-19(28)24-21(22-14)27-18(12-15(2)25-27)23-20(29)16-6-8-17(9-7-16)32(30,31)26-10-4-3-5-11-26/h6-9,12-13H,3-5,10-11H2,1-2H3,(H,23,29)(H,22,24,28)

InChI Key

NATOUURCCCYGIK-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD08536760

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

456.53

Hydrogen Bond Acceptors Count

11.00

Hydrogen Bond Donors Count

2.00

Rotatable Bond Count

6.00

Number of Nitrogen and Oxygen Atoms

10

Partition Coefficient, logP

1.343

Distribution Coefficient, logD

0.691

Water Solubility, LogSw

-2.45

Polar Surface Area

103.347

Acid Dissociation Constant (pKa)

6.86

Base Dissociation Constant (pKb)

-2.74

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

33.30

F269-0081 in Drug Discovery

Included in Screening Libraries

Allosteric Kinases Inhibitors Library (23117 compounds)

Anticancer Library (62698 compounds)

Arginase Targeted Library (2009 compounds)

RNA-Protein Interaction Inhibitors Library (1986 compounds)

ChemoGenomic Annotated Library for Phenotypic Screening (89798 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer
  • Female
  • Congenital
  • Skin
  • Cancer
  • Cancer
  • Musculoskeletal
  • Male
  • Cardiovascular
Targets:
  • Kinases
  • Others

References: we are preparing a list of scientific research reports with F269-0081 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound F269-0081?
Check Price and Availability of F269-0081, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of F269-0081 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for F269-0081
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for F269-0081
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of F269-0081 available by request